DaVita
DVA
#1846
Rank
C$16.43 B
Marketcap
C$256.01
Share price
-0.04%
Change (1 day)
44.25%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$15.15

According to DaVita's latest financial reports the company's current EPS (TTM) is C$15.33. In 2025 the company made an earnings per share (EPS) of C$14.10 a decrease over its 2024 EPS that were of C$15.37.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$15.157.41%
2025C$14.10-8.25%
2024C$15.3744.94%
2023C$10.6127.26%
2022C$8.33-35.56%
2021C$12.9344.1%
2020C$8.9819.7%
2019C$7.50540.48%
2018C$1.17-76.07%
2017C$4.89-19.31%
2016C$6.06242.52%
2015C$1.77-62.87%
2014C$4.7713.43%
2013C$4.208.45%
2012C$3.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$33.88 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$15.83 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$27.02 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.88-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA